Acurx制药公司宣布,其针对DNA聚合酶IIIC抑制剂的研究成果,在莱顿大学医学中心主导的公私合作项目中取得进展。这些关键数据已在莱顿早期药物发现与开发科学会议上进行展示。
Acurx制药公司宣布,其针对DNA聚合酶IIIC抑制剂的研究成果,在莱顿大学医学中心主导的公私合作项目中取得进展。这些关键数据已在莱顿早期药物发现与开发科学会议上进行展示。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.